Clinical Efficacy and Immunological Mechanisms of Telitacicept in the Treatment of Sjögren’s Disease Complicated with Interstitial Lung Disease

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 53ca9ef680c2d63f75fe1bf212f374b747c544b8
First added on: Oct 10, 2026